Le Travenues Technology Future Growth
Future criteria checks 5/6
Le Travenues Technology is forecast to grow earnings and revenue by 28.8% and 21.9% per annum respectively. EPS is expected to grow by 20.4% per annum. Return on equity is forecast to be 17.2% in 3 years.
Key information
28.8%
Earnings growth rate
20.4%
EPS growth rate
| Hospitality earnings growth | 42.6% |
| Revenue growth rate | 21.9% |
| Future return on equity | 17.2% |
| Analyst coverage | Low |
| Last updated | 14 Nov 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 3/31/2027 | 12,492 | 1,195 | 836 | 931 | 1 |
| 3/31/2026 | 10,086 | 864 | 493 | 551 | 1 |
| 3/31/2025 | 8,234 | 551 | 570 | 576 | 1 |
| 9/30/2024 | 7,237 | 670 | 924 | 942 | N/A |
| 6/30/2024 | 6,812 | 819 | N/A | N/A | N/A |
| 3/31/2024 | 6,559 | 758 | 359 | 432 | N/A |
| 12/31/2023 | 6,280 | 713 | 165 | 265 | N/A |
| 6/30/2023 | 5,390 | 223 | N/A | N/A | N/A |
| 3/31/2023 | 5,013 | 216 | 252 | 307 | N/A |
| 6/30/2022 | 4,420 | -120 | -32 | -13 | N/A |
| 3/31/2022 | 3,796 | -244 | -363 | -343 | N/A |
| 3/31/2021 | 1,356 | 72 | -153 | -152 | N/A |
| 3/31/2020 | 1,116 | -266 | 332 | 340 | N/A |
| 3/31/2019 | 404 | -574 | -428 | -423 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IXIGO's forecast earnings growth (28.8% per year) is above the savings rate (6.7%).
Earnings vs Market: IXIGO's earnings (28.8% per year) are forecast to grow faster than the Indian market (18% per year).
High Growth Earnings: IXIGO's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IXIGO's revenue (21.9% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: IXIGO's revenue (21.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: IXIGO's Return on Equity is forecast to be low in 3 years time (17.2%).